Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
  1. 4 Insider Changes in Ownership
  2. 4 Grant or award Chief People Officer acquired 1,036 shares (grant or award)
  3. 4 Open-market sale Director sold 6,424 shares at $19.25 ($123,673)
  4. 4 Grant or award Director acquired 17,275 shares (grant or award)
  5. 4 Grant or award Director acquired 17,275 shares (grant or award)
  6. 4 Grant or award Director acquired 17,275 shares (grant or award)
  7. 4 Grant or award Director acquired 17,275 shares (grant or award)
  8. 4 Grant or award Director acquired 17,275 shares (grant or award)
  9. 4 Grant or award Director acquired 17,275 shares (grant or award)
  10. 4 Grant or award Director acquired 17,275 shares (grant or award)
  11. 4 Grant or award Director acquired 17,275 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Grant or award Chief Scientific Officer acquired 7,500 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award Chief Commercial Officer acquired 10,000 shares (grant or award)
  17. 4 Shares withheld for taxes Chief Growth Officer gave up 2,976 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Technology Officer gave up 2,842 shares (to pay taxes)
  19. 4 Shares withheld for taxes President, Mental Health gave up 2,666 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief People Officer gave up 3,641 shares (to pay taxes)

Page 14 of 65 · 1,293 filings